Biodel (BIOD)
Biodel Accounts Receivable: 0.035M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
BIOD Accounts Receivable Rankings
| Overall | 0th percentile | 3746 of 3768 |
| Sector | 2nd percentile | 430 of 442 in Healthcare |
| Industry | 2nd percentile | 33 of 34 in Drug Manufacturers - Other |
BIOD Accounts Receivable Range, Past 5 Years
| Minimum | 0.035M | Dec 2011 |
| Maximum | 2.226M | Jun 2010 |
| Average | 1.062M |
About Accounts Receivable
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
YCharts takes accounts receivable from the balance sheet of a company. It is reported net of allowance for bad debts.
Learn More
You may also be interested in these BIOD related companies
BIOD News
$BIOD http://stks.co/3zVn 4HR view; 10 ready to cross 50, needs to break into the kumo
about 3 days ago by Tr8r_x
about 3 days ago by Tr8r_x
$BIOD http://stks.co/3yiM Battling the 200 day, 10, 50 & 200 converging
about 3 days ago by Tr8r_x
about 3 days ago by Tr8r_x
Biodel Announces Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market
May 10, 3:32PM PR Newswire
May 10, 3:32PM PR Newswire
Biodel to Report Second Quarter Fiscal Year 2012 Financial Results on May 10, 2012
May 07, 6:00AM PR Newswire
May 07, 6:00AM PR Newswire
$BIOD is being mentioned 23x the normal amount on Stocktwits 4,445.5% increase in mentions
about 32 days ago by TradeIdeas1
about 32 days ago by TradeIdeas1
$BIOD just hit $1...the strength that this stock has shown since Monday is incredible...Interesting to see how much it has left
about 32 days ago by investorgadget
about 32 days ago by investorgadget
@oliveblakcok speaking of pump $BIOD yea right LOL speaking of timber next i guess
about 32 days ago by biotech
about 32 days ago by biotech
$cycc too bad you keep pumping this crap...you could have been in $biod
about 32 days ago by oliveblakcok
about 32 days ago by oliveblakcok
Biodel to Provide Update on Stabilized Glucagon Program at ROTH Conference Today
Mar 14, 4:00PM PR Newswire
Mar 14, 4:00PM PR Newswire
Biodel Inc. to Present at ROTH 24th Annual OC Growth Stock Conference on March 14th, 2012
Mar 08, 6:00AM PR Newswire
Mar 08, 6:00AM PR Newswire
Biodel to Report First Quarter Fiscal Year 2012 Financial Results on February 8, 2012
Feb 03, 6:59AM PR Newswire
Feb 03, 6:59AM PR Newswire
Biodel (BIOD) Gets Orphan Designation Suggestion from EMA COMP for CHI Treatment Glucagon
Jan 20, 7:04AM Street Insider
Jan 20, 7:04AM Street Insider
Biodel Inc. to Present at 30th Annual JPMorgan Healthcare Conference on January 12th, 2012
Jan 06, 6:59AM PR Newswire
Jan 06, 6:59AM PR Newswire
Biodel to Report Fourth Quarter Fiscal Year 2011 Financial Results on December 6, 2011
Dec 01, 4:00PM PR Newswire
Dec 01, 4:00PM PR Newswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BIOD | 0.76 | +0.01 | +1.47% | 29.42M |
| BIOB | 107.27 | +0.67 | +0.63% | 3.053B |
| BIO | 101.39 | -0.63 | -0.62% | 2.859B |
| BIN | 19.71 | -0.18 | -0.91% | 2.312B |
| BIK | 20.72 | -0.02 | -0.10% | |
| BIIB | 131.56 | -0.09 | -0.07% | 31.41B |
| BIG | 37.30 | +1.55 | +4.34% | 2.469B |
| BIF | 5.73 | +0.01 | +0.17% | |
| BIDZ | 0.76 | +0.01 | +0.66% | 13.97M |
| BDN | 11.29 | -0.07 | -0.62% | 1.611B |
